AAAAAA
Results:
1-8
|
Results: 8
Authors:
Stendel, R
Krischek, B
Pietila, TA
Citation: R. Stendel et al., Biodegradable implants in neurosurgery, ACT NEUROCH, 143(3), 2001, pp. 237-243
Authors:
Schenk, JF
Stephan, B
Morsdorf, S
Tilev, K
Krischek, B
Wenzel, E
Trumper, L
Seyfert, UT
Citation: Jf. Schenk et al., Rational use of blood and blood components in hematology and oncology, INFUS THER, 27(4), 2000, pp. 190-194
Authors:
Schenk, JF
Berg, G
Morsdorf, S
Stefan, B
Kroll, H
Krischek, B
Pindur, G
Schieffer, H
Wenzel, E
Citation: Jf. Schenk et al., Heparin-induced thrombocytopenia: A critical risk/benefit analysis of patients in intensive care treated with r-hirudin, CL APPL T-H, 6(3), 2000, pp. 151-156
Authors:
Morsdorf, S
Leipnitz, G
Pindur, G
Schenk, JF
Erdlenbruch, W
Krischek, B
Wenzel, E
Citation: S. Morsdorf et al., Improved therapeutic safety of oral anticoagulant therapy in Germany: The Saarland model, SEM THROMB, 25(1), 1999, pp. 49-55
Authors:
Sandvoss, G
Erdlenbruch, W
Krischek, B
Citation: G. Sandvoss et al., Phenprocoumon from a neurosurgical perspective, SEM THROMB, 25(1), 1999, pp. 73-77
Authors:
Pindur, G
Morsdorf, S
Schenk, JF
Krischek, B
Heinrich, W
Wenzel, E
Citation: G. Pindur et al., The overdosed patient and bleedings with oral anticoagulation, SEM THROMB, 25(1), 1999, pp. 85-88
Authors:
Morsdorf, S
Erdlenbruch, W
Taborski, U
Schenk, JF
Erdlenbruch, K
Novotny-Reichert, G
Krischek, B
Wenzel, E
Citation: S. Morsdorf et al., Training of patients for self-management of oral anticoagulant therapy: Standards, patient suitability, and clinical aspects, SEM THROMB, 25(1), 1999, pp. 109-115
Authors:
Wenzel, T
Morsdorf, S
Sibitz, I
Schenck, JF
Griengl, H
Erdlenbruch, W
Heinrich, W
Krischek, B
Birner, P
Harenberg, J
Citation: T. Wenzel et al., Dimensions of quality of life and self-monitoring therapy with oral anticoagulants - Still research or everyday practice?, SEM THROMB, 25(1), 1999, pp. 117-121
Risultati:
1-8
|